Работы, цитирующие эту работу

Работ: 2

Работа: PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

1. Clinical, Immunological And Molecular-Genetic Characteristic Of Aggressive Pituitary Adenomas

   Khalimova Zamira Yusufovna

   СтатьяPituitary Gland Disorders and TreatmentsThe American Journal of Medical Sciences and Pharmaceutical Research2021Цитирований: 0

   ABIABI:AkademIndex/openalex/2021.article.002729

2. Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors

   Suleiman Ibrahim Mohammad, Malika Ruzibakieva, Reena Gupta +7

   СтатьяRNA modifications and cancerCell Biochemistry and Function2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.article.001262